Search

everythinglearnresearchcommunity

for

Search:↓

The study evaluated how alopecia areata severity relates to its psychosocial effects on patients.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Anti-androgens might help reduce COVID-19 severity in men.

Most COVID-19 survivors developed post-acute symptoms, especially if they had been in the ICU, but the severity of initial infection didn't predict these symptoms.

Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Hormonal status from androgen deprivation therapy may affect COVID-19 severity in men.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

Good nutrition and essential trace elements like zinc, selenium, and iron are important for a strong immune system and reducing COVID-19 severity.

Old age, male sex, smoking, and obesity may affect COVID-19 severity, but more research is needed.

Women with high androgen levels may have more severe COVID-19 symptoms.

Severe COVID-19 increases the risk of hair loss.

Androgens play a key role in causing alopecia by changing the hair growth cycle.

Psoriasis treatments don't raise severe COVID-19 risk, except for acitretin.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

COVID-19 symptoms range from mild to severe, with older adults at higher risk.

Androgenic alopecia is linked to more severe COVID-19 and higher mortality.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

COVID-19 affects multiple body systems, not just the lungs.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

Men with severe balding have a higher risk of getting very sick from COVID-19.

Neuropathic pain is common in long COVID patients, especially those with depression or severe COVID-19.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.